...
首页> 外文期刊>BMC Genomics >Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology
【24h】

Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology

机译:利用精确的探针作图方法对转录谱分析技术进行多平台评估

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The arrival of RNA-seq as a high-throughput method competitive to the established microarray technologies has necessarily driven a need for comparative evaluation. To date, cross-platform comparisons of these technologies have been relatively few in number of platforms analyzed and were typically gene name annotation oriented. Here, we present a more extensive and yet precise assessment to elucidate differences and similarities in performance of numerous aspects including dynamic range, fidelity of raw signal and fold-change with sample titration, and concordance with qRT-PCR (TaqMan). To ensure that these results were not confounded by incompatible comparisons, we introduce the concept of probe mapping directed “transcript pattern”. A transcript pattern identifies probe(set)s across platforms that target a common set of transcripts for a specific gene. Thus, three levels of data were examined: entire data sets, data derived from a subset of 15,442 RefSeq genes common across platforms, and data derived from the transcript pattern defined subset of 7,034 RefSeq genes. In general, there were substantial core similarities between all 6 platforms evaluated; but, to varying degrees, the two RNA-seq protocols outperformed three of the four microarray platforms in most categories. Notably, a fourth microarray platform, Agilent with a modified protocol, was comparable, or marginally superior, to the RNA-seq protocols within these same assessments, especially in regards to fold-change evaluation. Furthermore, these 3 platforms (Agilent and two RNA-seq methods) demonstrated over 80?% fold-change concordance with the gold standard qRT-PCR (TaqMan). This study suggests that microarrays can perform on nearly equal footing with RNA-seq, in certain key features, specifically when the dynamic range is comparable. Furthermore, the concept of a transcript pattern has been introduced that may minimize potential confounding factors of multi-platform comparison and may be useful for similar evaluations.
机译:RNA-seq作为一种高通量方法,已经与已建立的微阵列技术竞争,因此必然推动了对比较评估的需求。迄今为止,这些技术的跨平台比较在所分析的平台数量上相对较少,并且通常以基因名称注释为导向。在这里,我们提出了更广泛而精确的评估方法,以阐明许多方面在性能上的差异和相似之处,包括动态范围,原始信号的保真度和样品滴定倍数变化以及与qRT-PCR(TaqMan)的一致性。为了确保这些结果不会因不兼容的比较而混淆,我们引入了探针映射指导的“转录本模式”的概念。转录本模式可识别跨平台的探针(组),这些探针针对特定基因的通用转录本集。因此,检查了三个级别的数据:整个数据集,从跨平台通用的15,442个RefSeq基因的子集衍生的数据以及从7,034个RefSeq基因的转录本模式定义的子集衍生的数据。总体而言,所评估的所有6个平台之间都存在实质性的核心相似之处;但是,在大多数类别中,两种RNA-seq协议在不同程度上都优于四种微阵列平台中的三种。值得注意的是,在相同的评估中,尤其是在倍数变化评估方面,第四个微阵列平台(具有改进方案的安捷伦)在这些相同的评估中与RNA-seq方案相当或略胜一筹。此外,这三个平台(Agilent和两个RNA-seq方法)证明了与金标准qRT-PCR(TaqMan)的折叠变化率超过80%。这项研究表明,在某些关键特征上,特别是在动态范围可比时,微阵列可以与RNA-seq几乎平等地发挥作用。此外,已经引入了转录本模式的概念,该概念可以最大程度地减少多平台比较的潜在混淆因素,并且可能对类似的评估有用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号